Impact of susceptibility to antibiotics of streptococci & enterococci isolated from patients with infective endocarditis on antibiotic treatment

Indian Journal of Medical Research, Supplement

Volumn 119, Issue MAY, 2004, Pages 80-83

  Mihaila Amrouche, Liliana ^a   Schlegel, Laurent ^a   Bouvet, Anne ^a   Leport, C ^b   Hoen, B ^b   Alla, F ^b   Beguinot I ^b   Briancon S ^b   Danchin, N ^b   Delahaye, F ^b   Etienne, J ^b   Ruimy, R ^b   Selton Suty, C ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Antibiotic treatment; Enterococci; Infective endocarditis; Prophylaxis; Streptococci

Indexed keywords

AGAR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; PRISTINAMYCIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILUTION; DRUG HYPERSENSITIVITY; DRUG USE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; FRANCE; HEALTH SURVEY; HUMAN; INFECTION PREVENTION; MINIMUM INHIBITORY CONCENTRATION; MOUTH INFECTION; NONHUMAN; PREVALENCE; PROSPECTIVE STUDY; SPECIES DIFFERENCE; SPECIES IDENTIFICATION; STREPTOCOCCACEAE; STREPTOCOCCUS; STREPTOCOCCUS GALLOLYTICUS;

ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS; HUMANS; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; STREPTOCOCCUS;

EID: 3442901673     PISSN: 03679012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briançon S, et al. Changing profile of infective endocarditis - results of a 1-year survey in France. JAMA 2002; 288: 75-81.
2. Herrero IA, Rouse MS, Piper KE, Alyaseen SA, Steckelberg JM, Patel R. Reevaluation of Streptococcus bovis endocarditis cases from 1975 to 1985 by 16s ribosomal DNA sequence analysis. J Clin Microbiol 2002; 40: 3848-50.
3. Bouvet A. Endocardite Infectieuse: Enquête en France 1990-1991. Sensibilité aux antibiotiques des Streptocoques et Enterocoques. Méd Mal Infect 1992; 22 Suppl: 987-92.
4. Mihaila-Amrouche L, Schlegel L, Collobert G, Bouvet A. Evolution de la sensibilité aux antibiotiques des souches de streptocoques et enterocoques responsables d'endocardites infectieuses en France de 1990 à 1999. Méd Mal Infect 2002; 32: 618-23.
5. Durack DT, Lukes AJ, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 200-9.
6. Facklam RR, Washington J A II. Streptococus and related catalase - negative Gram-positive cocci. In: Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ, editors. Manual of clinical microbiology, 5th ed.Washington DC: American Society for Microbiology; 1991 p. 238-57.
7. Osawa R, Fujisawa T, Sly LI. Streptococcus gallolyticus sp. nov.; gallate degrading organisms formerly assigned to Streptococcus bovis. Syst Appl Microbiol 1995; 18: 75-8.
8. Bouvet A, Grimont F, Collins MD, Benaoudia F, Devine C, Regnault B, et al. Streptococcus infantarius sp. nov. related to Streptococcus bovis and Streptococcus equinus. Adv Exp Med Biol 1997; 418: 393-5.
9. Schlegel L, Grimont F, Ageron E, Grimont PAD, Bouvet A. Reappraisal of the taxonomy of the Streptoccocus bovis / Streptococcus equinus complex and related species description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov., and S. gallolyticus subsp. pasteurianus subsp. nov. Int J Syst Evol Microbiol 2003; 53 (Pt 3): 631-45.
10. Courvalin P, Soussy CJ. Report of the Comite de l'Antibiogramme de la Societe Francaise de Microbiologie. Technical recommendations for in vitro susceptibility testing. Clin Microbiol Infect 1996; 2 (Suppl 1): 11-25.
11. Comite de l'antibiogramme de la Societe Francaise de Microbiologie report 2003. Int J Antimicrob Agents 2003; 21: 364-91.
12. Seppäla H, Nissinen A, Yu Q, Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993; 32: 885-91.
13. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995; 274: 1706-13.
14. Cinquième Conférence de Consensus en thérapeutique anti-infectieuse de la Société de Pathologie Infectieuse de Langue française Paris 27 mars 1992. Méd Mal Infect 1992; 22 (Suppl): 1119-41.
15. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997; 277: 1794-801.